GE HealthCare Technologies (GEHC) EBIAT (2022 - 2026)

GE HealthCare Technologies has reported EBIAT for 5 years, with the latest figure at $411.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBIAT fell 27.13% year-over-year to $411.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (down 6.91% YoY), and the FY2025 full-year result was $2.2 billion, up 8.08% from the prior year.
• EBIAT for Q1 2026 stood at $411.0 million, down from $659.0 million in the prior quarter.
• The five-year high for EBIAT was $681.0 million in Q4 2024, with the low at $372.0 million in Q1 2023.
• Historically, EBIAT has averaged $477.1 million across 5 years, with a median of $464.0 million in 2025.
• Annual changes were most pronounced in 2023 — EBIAT decreased 28.97% — and 2024, when it surged 67.32%.
• GE HealthCare Technologies' EBIAT stood at $573.0 million in 2022, then declined by 28.97% to $407.0 million in 2023, then surged by 67.32% to $681.0 million in 2024, then fell by 3.23% to $659.0 million in 2025, then slumped by 37.63% to $411.0 million in 2026.
• The last three EBIAT figures came in at $411.0 million (Q1 2026), $659.0 million (Q4 2025), and $464.0 million (Q3 2025), per Business Quant data.